Dr. Teja MullapudiAnalyst, Technology & Venture Development
Teja Mullapudi performs market opportunity assessment and scientific due diligence to determine the commercialization potential of projects entering TIAP’s pipeline. He also scouts for promising science and innovation from TIAP’s academic member institutions.
Prior to joining TIAP, Teja conducted market opportunity assessment for a software-as-a-service firm that aimed to enter the healthcare market. During his doctoral training in Prof. Didier Stainier’s lab at the Max Planck for Heart & Lung Research, Teja identified potentially first-in-class anti-diabetic agents to regulate glucose levels through insulin-independent mechanisms. His other past experiences include research on adipose cell biology at Prof. Alexander Pfeifer’s lab at the University of Bonn, and on human immunodeficiency virus (HIV) at the Indian Institute of Technology Madras and the National AIDS Research Institute, India.
Teja holds a Ph.D. from Goethe University, Frankfurt (Dec 2019) in Germany and an M.Tech + B.Tech in Biotechnology from the Indian Institute of Technology Madras in India.